HFM
GILD icon

Hartford Funds Management’s Gilead Sciences GILD Stock Holding History

Hartford Funds Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.33M Buy
18,436
+261
+1% +$34.4K 0.19% 28
2026
Q1 		$2.53M Buy
18,175
+481
+3% +$67.4K 0.22% 21
2025
Q4 		$2.17M Buy
17,694
+4,846
+38% +$589K 0.18% 26
2025
Q3 		$1.43M Sell
12,848
-1,433
-10% -$163K 0.12% 27
2025
Q2 		$1.58M Buy
14,281
+7,034
+97% +$749K 0.14% 24
2025
Q1 		$812K Buy
7,247
+1,318
+22% +$136K 0.07% 66
2024
Q4 		$548K Buy
+5,929
New +$534K 0.05% 79

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hartford Funds Management's GILD Position: Q2 2026 in Review

Hartford Funds Management increased its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, buying an estimated $34.4K and bringing the position to 18,436 shares worth $2.33M. The position accounts for 0.19% of the portfolio, ranked #28.

Hartford Funds Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.53M in Q1 2026. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Hartford Funds Management held 18,436 shares of Gilead Sciences worth $2.33M as of Q2 2026.
  • Hartford Funds Management bought 261 Gilead Sciences shares in Q2 2026, an estimated $34.4K.
  • Gilead Sciences made up 0.19% of Hartford Funds Management's portfolio in Q2 2026, its #28 holding.
  • Hartford Funds Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Hartford Funds Management's Gilead Sciences position peaked at $2.53M in Q1 2026.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Hartford Funds Management's 13F filing for Q2 2026, filed 6 Aug 2026.